Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Debt / NOTE 2.500% 1/1
-
Market price (% of par)
-
158.0%
-
Total 13F principal
-
$398,729,012
-
Principal change
-
+$3,417,003
-
Total reported market value
-
$629,971,196
-
Number of holders
-
39
-
Value change
-
+$23,985,748
-
Number of buys
-
21
-
Number of sells
-
24
Institutional Holders of MEDICINES CO - NOTE 2.500% 1/1 as of Q1 2017
As of 31 Mar 2017,
MEDICINES CO - NOTE 2.500% 1/1 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$398,729,012
in principal (par value) of the bond.
The largest 10 bondholders included
WOLVERINE ASSET MANAGEMENT LLC, CNH PARTNERS LLC, LINDEN ADVISORS LP, UBS ASSET MANAGEMENT AMERICAS INC, CAPSTONE INVESTMENT ADVISORS, LLC, CITADEL ADVISORS LLC, Polar Asset Management Partners Inc., LAZARD ASSET MANAGEMENT LLC, Myriad Asset Management Ltd., and DEUTSCHE BANK AG\.
This page lists
39
institutional bondholders reporting positions
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.